Education
About Us
Working with TipRanks
Follow Us
Kilitch Drugs (India) Limited (IN:KILITCH)
:KILITCH
Total Valuation
Kilitch Drugs (India) Limited has a market cap or net worth of ₹7.32B. The enterprise value is ₹6.20B.
Market Cap₹7.32B
Enterprise Value₹6.20B
Share Statistics
Kilitch Drugs (India) Limited has 16,082,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,082,320
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kilitch Drugs (India) Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.20%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)8.20%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.63
Inventory Turnover6.83
Valuation Ratios
The current PE Ratio of Kilitch Drugs (India) Limited is 21.69. Kilitch Drugs (India) Limited’s PEG ratio is -2.58.
PE Ratio21.69
PS Ratio0.00
PB Ratio2.34
Price to Fair Value2.86
Price to FCF-15.13
Price to Operating Cash Flow974.20
PEG Ratio-2.58
Income Statement
In the last 12 months, Kilitch Drugs (India) Limited had revenue of 1.98B and earned 267.01M in profits. Earnings per share was 16.60.
Revenue1.98B
Gross Profit937.39M
Operating Income283.55M
Pretax Income344.74M
Net Income267.01M
EBITDA426.26M
Earnings Per Share (EPS)16.60
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Kilitch Drugs (India) Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of ―
Dividend Per Share₹0.5
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.98
52-Week Price Change40.85%
50-Day Moving Average406.78
200-Day Moving Average349.51
Relative Strength Index (RSI)56.21
Average Volume (3m)9.53K
Important Dates
Kilitch Drugs (India) Limited upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMay 19, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateSep 20, 2019
Financial Position
Kilitch Drugs (India) Limited as a current ratio of 2.06, with Debt / Equity ratio of 7.81%
Current Ratio2.06
Quick Ratio1.88
Debt to Market Cap0.09
Net Debt to EBITDA0.93
Interest Coverage Ratio5.62
Taxes
In the past 12 months, Kilitch Drugs (India) Limited has paid 95.34M in taxes.
Income Tax95.34M
Effective Tax Rate0.28
Enterprise Valuation
Kilitch Drugs (India) Limited EV to EBITDA ratio is 14.52, with an EV/FCF ratio of -21.10.
EV to Sales3.12
EV to EBITDA14.52
EV to Free Cash Flow-21.10
EV to Operating Cash Flow35.27
Balance Sheet
Kilitch Drugs (India) Limited has ₹593.98M in cash and marketable securities with ₹494.24M in debt, giving a net cash position of -₹99.73M billion.
Cash & Marketable Securities₹593.98M
Total Debt₹494.24M
Net Cash-₹99.73M
Net Cash Per Share-₹6.20
Tangible Book Value Per Share₹112.88
Margins
Gross margin is 41.61%, with operating margin of 14.30%, and net profit margin of 13.46%.
Gross Margin41.61%
Operating Margin14.30%
Pretax Margin17.38%
Net Profit Margin13.46%
EBITDA Margin21.49%
EBIT Margin19.93%
Analyst Forecast
The average price target for Kilitch Drugs (India) Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―